Rare diseases
Investigational molecules
Locations
Back to Hungary164 clinical trials in Nyiregyhaza, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
HungaryPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
HungaryKAI-9531 in Adults With Obesity or Overweight and Diabetes
HungaryA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
HungaryA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
HungaryStudy of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk
HungaryStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
HungaryEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
HungaryStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
HungaryStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
HungaryEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
HungaryA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies for triple-negative and HR-positive/HER2-negative variants. Research extends to bladder cancer and lymphoma treatments.
Several studies are evaluating novel drug combinations and comparing their efficacy to standard treatments.
Comprehensive research into heart failure prevention and treatment of cardiovascular disease. Studies include innovative approaches for managing chronic conditions.
Trials are investigating new therapeutic combinations to improve patient outcomes in cardiovascular conditions.
Studies addressing chronic rhinosinusitis and respiratory infections, with particular focus on nasal polyps treatment and viral lung infections.
Research includes both preventive measures and therapeutic interventions for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
